Setting Standards

​Abio Technologies stands at the forefront of stem cell and exosome science, ​with Korea's first human stem cell culture facility since 2006.

Industry Disruptor

Abio Technologies leads the field of stem cell and exosome science as Korea's first human stem cell culture facility. For over 18 years, Abio produced and supplied high-quality stem cell products using independently developed media. Our commitment to innovation is evident in our leading patented Exotraction™ technology, which enables mass production and purification of highest-purity exosomes.

Unparalleled R&D

​With 33 patents for advanced technology and established state-of-the-art smart farm cultivation facilities, Abio also operates Korea's largest freeze-drying plant, ensuring the preservation of product quality. Abio's FDA, EU, and KFDA authorizations, along with full compliance with KFDA human stem cell and tissue culture media safety standards, guarantee reliable, safe, and stable products.

Advanced Exosome Manufacturing

Purest Concentration
​Cellexosome®​ contains 95% pure exosome concentrate per vial.

Reputable Sources®
CellExosome® only uses raw ingredients from ethical & reputable sources.

Controlled Process
​CellExosome®, uses patented Exotraction® technology that ensures the highest quality stable exosome extract every time.

Advanced Cryo-Tech
Cellexosome's® is cryo frozen in Korea's largest most advanced freeze drying facility for superior performance and shelf life.

Origin Technology
Abio Material's pioneering technology is created in a FDA/EU/KFDA approved facility

20 Billion particles

CellExosome® contains over 20 Billion exosome particles which can be utilized to target various skin conditions without the risk of overdosing.